Pneumococcal Vaccine Uptake Among Australian Hajj Pilgrims in 2011-13

The uptake of the pneumococcal vaccine is suboptimal in Australia and remains unknown among Australian Hajj pilgrims, many of whom are eligible because of age or underlying disease and at particular risk because of travel and activities at Hajj. Pneumococcal vaccination uptake was examined over thre...

Full description

Saved in:
Bibliographic Details
Published inInfectious disorders drug targets Vol. 14; no. 2; p. 117
Main Authors Tashani, Mohamed, Barasheed, Osamah, Azeem, Mohammad, Alfelali, Mohammad, Badahdah, Al-Mamoon, Bokhary, Hamid, Almasri, Nedal, Alshehri, Jassir, Matbouly, Ghassan, Kalantan, Nadeen, Heron, Leon, Ridda, Iman, Haworth, Elizabeth, Asghar, Atif, Rashid, Harunor, Booy, Robert
Format Journal Article
LanguageEnglish
Published United Arab Emirates 2014
Subjects
Adolescent
Adult
Age Factors
Australia
Chronic Disease - epidemiology
Cross-Sectional Studies
Female
Health Surveys
Humans
Islam
Male
Middle Aged
Pneumococcal Infections - prevention & control
Pneumococcal Vaccines
Saudi Arabia
Sex Factors
Surveys and Questionnaires
Travel
Vaccination - statistics & numerical data
Vaccination - trends
Young Adult
Online AccessGet more information

Cover

More Information
Summary:The uptake of the pneumococcal vaccine is suboptimal in Australia and remains unknown among Australian Hajj pilgrims, many of whom are eligible because of age or underlying disease and at particular risk because of travel and activities at Hajj. Pneumococcal vaccination uptake was examined over three consecutive years (2011 to 2013) through anonymous self-administered cross sectional surveys among Australian pilgrims who assembled in Mina valley, Mecca, Saudi Arabia. Respectively, 158, 513 and 219 pilgrims were recruited in 2011, 2012 and 2013; their mean ages were 43.8 (SD±13), 43 (SD±13.5) and 42.6 (SD±12.3) years; males accounted for 67 (42.4%), 325 (63.4%) and 172 (78.5%). Pneumococcal vaccine uptake rates were 28.5% (45/158), 28.7% (147/513) and 14.2% (31/219); among the pilgrims with 'at risk' conditions the pneumococcal vaccine uptake rates were 15 (30.6%), 43 (45.3%) and 9 (29%) respectively. According to our surveys, the pneumococcal vaccine uptake among Australian pilgrims is low. Further research is needed to explore the reasons through a validated study.
ISSN:2212-3989